We are live on !
Find out more
Strategic Advocates Portfolio holdings
AUM
$25.8M
Turnover
16.08%
1-Year Est. Return
36.11%
This Fund
S&P 500
This Quarter Est. Return
+23.62%
1 Year Est. Return
+36.11%
3 Year Est. Return
+103.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25.8M
AUM Growth
+$3.23M
(+14%)
Cap. Flow
+$911
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
42.51%
Holding
286
New
19
Increased
69
Reduced
67
Closed
27
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard High Dividend Yield ETF
VYM
|
+$232K |
| 2 |
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$125K |
| 3 |
Vanguard Consumer Staples ETF
VDC
|
+$119K |
| 4 |
Schwab International Equity ETF
SCHF
|
+$112K |
| 5 |
Amphenol
APH
|
+$90.7K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Healthcare ETF
IYH
|
+$169K |
| 2 |
Fidelity Low Volatility Factor ETF
FDLO
|
+$145K |
| 3 |
Boston Scientific
BSX
|
+$71.8K |
| 4 |
Chevron
CVX
|
+$62.1K |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$59.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.47% |
| 2 | Technology | 19.07% |
| 3 | Industrials | 6.77% |
| 4 | Consumer Discretionary | 3.15% |
| 5 | Healthcare | 2.64% |
Similar funds
SCA
MP
MGM
Strategic Advocates's Q2 2026 Portfolio in Review
As of Q2 2026, Strategic Advocates held 286 positions worth $25.8M, up 14% from $22.6M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Strategic Advocates's Q2 2026 filing shows 19 new, 69 increased, 67 reduced and 27 closed positions. Its largest new stake was Lam Research: 250 shares worth $108K. The largest sale was iShares US Healthcare ETF, an estimated $169K.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, down from 65% a quarter earlier, followed by Technology and Industrials.
- Strategic Advocates's largest Q2 2026 buy was Lam Research: 250 shares worth $108K.
- Strategic Advocates added most to Vanguard High Dividend Yield ETF in Q2 2026, an estimated $232K increase.
- Strategic Advocates's biggest Q2 2026 reduction was iShares US Healthcare ETF, cutting an estimated $169K.
- Strategic Advocates fully exited Chevron in Q2 2026, selling an estimated $62.1K.
- Strategic Advocates's ten largest holdings make up 43% of its $25.8M portfolio in Q2 2026.
- Strategic Advocates opened 19 new positions and closed 27 in Q2 2026.
- Strategic Advocates's portfolio value rose 14% quarter-over-quarter to $25.8M.
Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.